Search Results

There are 22230 results for: content related to: Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  5. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  6. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  7. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22645

  8. You have free access to this content
    Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1719–1726, Vinod K. Rustgi, William M. Lee, Eric Lawitz, Stuart C. Gordon, Nezam Afdhal, Fred Poordad, Herbert L. Bonkovsky, Leif Bengtsson, Gurudatt Chandorkar, Matthew Harding, Lindsay McNair, Molly Aalyson, John Alam, Robert Kauffman, Shahin Gharakhanian, John G. McHutchison and MErimepodib TRiple cOmbination (METRO) study group

    Version of Record online : 5 AUG 2009, DOI: 10.1002/hep.23204

  9. You have free access to this content
    Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

    Hepatology

    Volume 49, Issue 6, June 2009, Pages: 1838–1846, Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo and Norman Gitlin

    Version of Record online : 2 FEB 2009, DOI: 10.1002/hep.22871

  10. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  11. Therapy for hepatitis C genotype 3: moving forward

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 683–690, M. Buti, J. Llaneras, M. Riveiro-Barciela and R. Esteban

    Version of Record online : 13 MAY 2015, DOI: 10.1111/jvh.12419

  12. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy

    Journal of Medical Virology

    Volume 88, Issue 10, October 2016, Pages: 1776–1784, Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Naoki Morishita, Ryoko Yamada, Takayuki Yakushijin, Atsushi Hosui, Masahide Oshita, Akira Kaneko, Hideki Hagiwara, Eiji Mita, Toshifumi Ito, Yukinori Yamada, Masami Inada, Kazuhiro Katayama, Shinji Tamura, Yasuharu Imai, Hayato Hikita, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 29 MAR 2016, DOI: 10.1002/jmv.24528

  13. You have free access to this content
    Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E84–E91, Hisashi Ishida, Sadatsugu Sakane, Takashi Toyama, Keisuke Fukutomi, Keiichi Kimura, Aya Sugimoto, Kenji Hibino, Takeshi Tamura, Tetsuya Iwasaki, Ryuichiro Iwasaki, Hiroko Hasegawa, Yuko Sakakibara, Takuya Yamada, Shoichi Nakazuru and Eiji Mita

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12224

  14. Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated-interferon and ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 201–207, Hoang Hai, Akihiro Tamori, Masaru Enomoto, Hiroyasu Morikawa, Sawako Uchida-Kobayashi, Hideki Fujii, Atsushi Hagihara, Etsushi Kawamura, Le Thi Thanh Thuy, Yasuhito Tanaka and Norifumi Kawada

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jgh.12376

  15. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  16. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Version of Record online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  17. You have free access to this content
    The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 749–758, Stefan Zeuzem, Peter Buggisch, Kosh Agarwal, Patrick Marcellin, Daniel Sereni, Hartwig Klinker, Christophe Moreno, Jean-Pierre Zarski, Yves Horsmans, Hongmei Mo, Sarah Arterburn, Steven Knox, David Oldach, John G. McHutchison, Michael P. Manns and Graham R. Foster

    Version of Record online : 23 FEB 2012, DOI: 10.1002/hep.24744

  18. You have free access to this content
    An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1433–1444, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 26 SEP 2011, DOI: 10.1002/hep.24641

  19. Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 15, Issue 9, September 2008, Pages: 623–633, M. Gambarin-Gelwan and I. M. Jacobson

    Version of Record online : 10 JUL 2008, DOI: 10.1111/j.1365-2893.2008.01018.x

  20. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950